🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this this hybrid safety/implementation study is to evaluate whe...
Status
Active Not Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2023-11-30
Trial ID
NCT05986084
Treatments Being Tested
The purpose of this study is to evaluate if offering long-acting injectable...
Status
Not Yet Recruiting
Location
Hôpital Hôtel Dieu
Start Date
2024-04-01
Trial ID
NCT06273943
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
The LATA trial will find out if taking a long-acting injectable form of HIV...
Status
Unknown
Location
Moi University
Start Date
2023-06-22
Trial ID
NCT05154747
Treatments Being Tested
This is a Phase I/II, multicenter, open-label, non-randomized study with fo...
Status
Withdrawn
Location
Site 4601, University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program
Start Date
2025-05-01
Trial ID
NCT06336434
Treatments Being Tested
Chronic human immunodeficiency virus (HIV) infection in adults continues to...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-08
Trial ID
NCT04001803
Treatments Being Tested
This study is being done to understand how long-acting injectable cabotegra...
Status
Not Yet Recruiting
Location
Princess Marina Hospital
Start Date
2026-08-01
Trial ID
NCT07516548
Treatments Being Tested
People Living with HIV-1 (PLHIV) are an important group of patients attendi...
Status
Recruiting
Location
Hospital General Universitario de Elche
Start Date
2025-03-03
Trial ID
NCT06646562
Treatments Being Tested
This sub-study will assess the pharmacokinetics (PK), safety, tolerability,...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-10-28
Trial ID
NCT05896761
Treatments Being Tested
IMPALA is a randomized, open-label, multicenter, interventional study of 54...
Status
Active Not Recruiting
Location
Jaramogi Oginga Odinga Teaching & Referral Hospital
Start Date
2022-12-08
Trial ID
NCT05546242
Treatments Being Tested